(Reuters) - Such gadolinium-based imaging agents are made by Bayer AG's Bayer Schering Pharma, General Electric Co's GE Healthcare, Tyco International Ltd's Mallinckrodt unit, and Bracco Diagnostics Inc., the FDA said.
Agency officials first alerted doctors to the potential risk in June 2006 and again in December 2006, following reports that patients who received the injectable agents developed nephrogenic systemic fibrosis, or NSF.
Read more at Reuters.com Government Filings News
Agency officials first alerted doctors to the potential risk in June 2006 and again in December 2006, following reports that patients who received the injectable agents developed nephrogenic systemic fibrosis, or NSF.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment